128 related articles for article (PubMed ID: 12962565)
21. Detection and significance of bcr-abl mRNA transcripts and fusion proteins in Philadelphia-positive adult acute lymphoblastic leukemia.
Tuszynski A; Dhut S; Young BD; Lister TA; Rohatiner AZ; Amess JA; Chaplin T; Dorey E; Gibbons B
Leukemia; 1993 Oct; 7(10):1504-8. PubMed ID: 8412311
[TBL] [Abstract][Full Text] [Related]
22. Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment.
Scheuring UJ; Pfeifer H; Wassmann B; Brück P; Gehrke B; Petershofen EK; Gschaidmeier H; Hoelzer D; Ottmann OG
Leukemia; 2003 Sep; 17(9):1700-6. PubMed ID: 12970767
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia.
Pfeifer H; Lange T; Wystub S; Wassmann B; Maier J; Binckebanck A; Giagounidis A; Stelljes M; Schmalzing M; Dührsen U; Wunderle L; Serve H; Brück P; Schmidt A; Hoelzer D; Ottmann OG
Leukemia; 2012 Jul; 26(7):1475-81. PubMed ID: 22230800
[TBL] [Abstract][Full Text] [Related]
24. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
25. BCR-ABL fusion protein detection in peripheral blood and bone marrow samples of adult precursor B-cell acute lymphoblastic leukemia patients using the flow cytometric immunobead assay.
Grigoriou EE; Psarra KK; Garofalaki MK; Tziotziou EC; Papasteriades CA
Clin Chem Lab Med; 2012 Mar; 50(9):1657-63. PubMed ID: 22962228
[TBL] [Abstract][Full Text] [Related]
26. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
[TBL] [Abstract][Full Text] [Related]
27. Association of cytogenetic abnormalities with detection of BCR-ABL fusion transcripts in children with T-lineage lymphoproliferative diseases (T-ALL and T-NHL).
Lo Nigro L; Sainati L; Mirabile E; Lanciotti M; Poli A; Leszl A; Basso G
Pediatr Blood Cancer; 2004 Mar; 42(3):278-80. PubMed ID: 14752867
[TBL] [Abstract][Full Text] [Related]
28. Comparative Analysis of Flow Cytometry and RQ-PCR for the Detection of Minimal Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Hematopoietic Stem Cell Transplantation.
Zhao X; Zhao X; Chen H; Qin Y; Xu L; Zhang X; Liu K; Huang X; Chang YJ
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1936-1943. PubMed ID: 29572111
[TBL] [Abstract][Full Text] [Related]
29. Miniaturized flow cytometry-based BCR-ABL immunoassay in detecting leptomeningeal disease.
D'Alessio F; Mirabelli P; Mariotti E; Raia M; Di Noto R; Fortunato G; Camera A; Del Vecchio L
Leuk Res; 2011 Oct; 35(10):1290-3. PubMed ID: 21658767
[TBL] [Abstract][Full Text] [Related]
30. Detection of BCR-ABL fusion proteins in patients with leukemia using a cytometric bead array.
Yujie W; Yu Z; Sixuan Q; Li W; Peng L; Zeng G; Sujiang Z; Jianyong L
Leuk Lymphoma; 2012 Mar; 53(3):451-5. PubMed ID: 21933042
[TBL] [Abstract][Full Text] [Related]
31. Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction.
Radich JP; Kopecky KJ; Boldt DH; Head D; Slovak ML; Babu R; Kirk J; Lee A; Kessler P; Appelbaum F
Leukemia; 1994 Oct; 8(10):1688-95. PubMed ID: 7934164
[TBL] [Abstract][Full Text] [Related]
32. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Matsue K; Tabayashi T; Yamada K; Takeuchi M
Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
[TBL] [Abstract][Full Text] [Related]
33. Rapid detection of BCR-ABL fusion genes using a novel combined LUX primer, in-cell RT-PCR and flow cytometric method.
Shi Y; Li LZ; Sun JZ; Zhang T; Peng J; Xu CG
Ann Hematol; 2008 Jan; 87(1):35-41. PubMed ID: 17846772
[TBL] [Abstract][Full Text] [Related]
34. Correlation of cytogenetics, BCR-ABL PCR studies and fluorescence in situ hybridisation (FISH) in adult acute lymphoblastic leukaemia.
Campbell LJ; Martinow A; Michael PM; White JS; Rayeroux KC; Januszewicz EH
Aust N Z J Med; 1999 Oct; 29(5):707-12. PubMed ID: 10630652
[TBL] [Abstract][Full Text] [Related]
35. BCR/ABL rearrangement in Philadelphia chromosome negative CML patients.
Rerkamnuaychoke B; Jomsawat U; Maneesri N; Apilugsanachit A; Pattanasak N
J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S70-5. PubMed ID: 10865410
[TBL] [Abstract][Full Text] [Related]
36. Undifferentiated immunophenotypes and not expression of BCR-ABL can be associated in adult Mestizo Mexican patients with ALL.
Vázquez-Franco JE; Reyes-Maldonado E; Montiel-Cervantes LA; Lezama RA
Rev Invest Clin; 2012; 64(1):32-9. PubMed ID: 22690527
[TBL] [Abstract][Full Text] [Related]
37. Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study.
Borowitz MJ; Pullen DJ; Shuster JJ; Viswanatha D; Montgomery K; Willman CL; Camitta B;
Leukemia; 2003 Aug; 17(8):1566-72. PubMed ID: 12886244
[TBL] [Abstract][Full Text] [Related]
38. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
[TBL] [Abstract][Full Text] [Related]
39. Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.
Guerrasio A; Pilatrino C; De Micheli D; Cilloni D; Serra A; Gottardi E; Parziale A; Marmont F; Diverio D; Divona M; Lo Coco F; Saglio G
Leukemia; 2002 Jun; 16(6):1176-81. PubMed ID: 12040450
[TBL] [Abstract][Full Text] [Related]
40. Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring.
Zaliova M; Fronkova E; Krejcikova K; Muzikova K; Mejstrikova E; Stary J; Trka J; Zuna J
Leukemia; 2009 May; 23(5):944-51. PubMed ID: 19158828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
